A carregar...
Randomized dose-finding study of batefenterol via dry powder inhaler in patients with COPD
BACKGROUND: Batefenterol is a novel bifunctional muscarinic antagonist β(2)-agonist in development for COPD. The primary objective of this randomized, double-blind, placebo-controlled, active comparator, Phase IIb study was to model the dose–response of batefenterol and select a dose for Phase III d...
Na minha lista:
| Publicado no: | Int J Chron Obstruct Pulmon Dis |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6413745/ https://ncbi.nlm.nih.gov/pubmed/30880951 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S190603 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|